Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Graft Versus Host Disease – Landscape & Forecast – Niche & Rare Disease Landscape & Forecast (US/EU5)
Graft versus host disease (GVHD) is a potentially life-threatening complication of allogenic hematopoietic stem cell transplantation (HSCT). Steroids have been the first-line therapy for the…
Psoriasis | Treatment Algorithms: Claims Data Analysis | Adult Psoriasis | US | 2024
The treatment of adult psoriasis represents an increasingly lucrative market for biologics for moderate to severe disease, for which conventional systemic and topical treatments are not sufficient…
Colorectal Cancer – Current Treatment – Current Treatment: Physician Insights – Colorectal Cancer (US)
Chemotherapy is the backbone of treatment for colorectal cancer, but treatment in the metastatic setting has expanded with the approval of several targeted agents. Well-established targeted…
Colorectal Cancer – Current Treatment – Treatment Sequencing – Colorectal Cancer (US)
Key benefits and usesPinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.Drill down into physicians’ treatment sequences and understand who to position against…
Immune Thrombocytopenic Purpura – Landscape & Forecast – Niche & Rare Disease Landscape & Forecast (US/EU5)
Immune thrombocytopenic purpura (ITP) is an autoimmune disease resulting in a low platelet count. Treatment of ITP involves the use of immunomodulators and corticosteroids as well as multiple…
Irritable Bowel Syndrome | Treatment Algorithms: Claims Data Analysis | IBS-Diarrhea | US | 2024
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency. It is generally grouped into three…